The use of open-label placebo alongside methadone for opioid use disorder was associated with greater 90-day treatment retention rates and better sleep quality compared with the use of methadone alone, a randomized clinical trial found.
“The clinical implications of our intervention have great potential impact, as retention in treatment is a serious challenge for the field of addiction medicine,” Annabelle M. Belcher, PhD, an assistant professor of psychiatry at the University of Maryland School of Medicine, said in a press release. “We’ve demonstrated it’s